GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annexin Pharmaceuticals AB (OSTO:ANNX) » Definitions » FFO

Annexin Pharmaceuticals AB (OSTO:ANNX) FFO


View and export this data going back to 2017. Start your Free Trial

What is Annexin Pharmaceuticals AB FFO?

FFO (Funds from operations) only applies to REITs.


Annexin Pharmaceuticals AB Business Description

Traded in Other Exchanges
N/A
Address
Norrtullsgatan 6, Stockholm, SWE, SE-113 29
Annexin Pharmaceuticals AB is a biotechnology company. It is developing biological drug candidate ANXV, a recombinant human protein Annexin A5 for treatment of various cardiovascular diseases. The company also focuses on development of ANXV for the treatment of retinal vein occlusion.